Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal for Immunotherapy of Cancer|July 17, 2020
Hematopoietic lineage-converted T cells carrying tumor-associated antigen-recognizing TCRs effectively kill tumor cellsFangxiao Hu, Dehao Huang, Yuxuan Luo, et al.
Cell Proliferation|August 13, 2024
Mesothelin CAR-engineered NK cells derived from human embryonic stem cells suppress the progression of human ovarian cancer in animalsYanhong Liu, Min Zhang, Xiaoyan Shen, et al.
Cell Proliferation|July 10, 2026
iPSC-Derived iNK Progenitors Engraft and Generate NK Cells in Unconditioned and Autologous Immune Humanized MiceMin Zhang, Zhiqian Wang, Yanhong Liu, et al.
Cellular & Molecular Immunology|December 11, 2021
Regeneration of immunocompetent B lymphopoiesis from pluripotent stem cells guided by transcription factorsQi Zhang, Bingyan Wu, Qitong Weng, et al.
Stem Cell Research|April 4, 2017
Pyrimidoindole derivative UM171 enhances derivation of hematopoietic progenitor cells from human pluripotent stem cellsXuejia Li, Chengxiang Xia, Tongjie Wang, et al.
Cell Proliferation|June 3, 2024
Comparison of seven CD19 CAR designs in engineering NK cells for enhancing anti-tumour activityYao Wang, Jianhuan Li, Zhiqian Wang, et al.
Frontiers in Immunology|December 12, 2024
Hypoimmunogenic CD19 CAR-NK cells derived from embryonic stem cells suppress the progression of human B-cell malignancies in xenograft animalsQi Zhang, Chengxiang Xia, Qitong Weng, et al.
Cell Stem Cell|February 26, 2026
Pluripotent stem cell-derived CAR-NK progenitor therapy targets minimal residual disease and prevents relapse in leukemia modelsZhiqian Wang, Leqiang Zhang, Dehao Huang, et al.
Cell Discovery|November 7, 2022
Lateral plate mesoderm cell-based organoid system for NK cell regeneration from human pluripotent stem cellsDehao Huang, Jianhuan Li, Fangxiao Hu, et al.
Nature Biomedical Engineering|October 7, 2025
Large-scale generation of iNK and CAR-iNK cells from CD34<sup>+</sup> haematopoietic stem and progenitor cells for adoptive immunotherapyFangxiao Hu, Jianhuan Li, Yao Wang, et al.
Pageof 3